Fig. 1From: Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver diseaseA The flow diagram of the present study. B The serum partial least squares-discriminant analysis (PLS-DA) score plot among non-MAFLD with or without CAS, nonobese MAFLD with or without CAS, and obese MAFLD with or without CAS. C The heat map of all differential metabolites, and metabolites with top 10 VIP value based on the partial least squares-discriminant analysis (PLS-DA), respectively. NOB-MAFLD, nonobese metabolic associated fatty liver disease; OB-MAFLD, obese metabolic associated fatty liver disease; CAS, carotid atherosclerosis; UHPLC-QTOF-LC-MS, ultrahigh-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry; QC-MS, gas chromatography-mass spectrometryBack to article page